A Psychonaut's Experience of Intoxication with Multiple Classes of Drugs Including Novel Psychoactive Substance 2-fluorodeschloroketamine: Case Report and Urinary Analysis.

Autor: Domanski K; School of Medicine, University of Nevada Reno, Reno, NV, USA.; Emergency Medicine, MountainView Hospital, Las Vegas, NV, USA., Fleming SW; North Louisiana Criminalistics Laboratory, Shreveport, LA, USA.; Louisiana State University Health Sciences Center Shreveport, Louisiana Addiction Research Center, Shreveport, LA, USA., Maag H; Emergency Medicine, MountainView Hospital, Hca Healthcare, Las Vegas, NV, USA., Bouso Raley E; North Louisiana Criminalistics Laboratory, Shreveport, LA, USA., DeBord J; North Louisiana Criminalistics Laboratory, Shreveport, LA, USA., Wright B; Emergency Medicine, MountainView Hospital, Las Vegas, NV, USA., Mahana R; Emergency Medicine, MountainView Hospital, Las Vegas, NV, USA.
Jazyk: angličtina
Zdroj: Journal of psychoactive drugs [J Psychoactive Drugs] 2022 Sep-Oct; Vol. 54 (4), pp. 319-323. Date of Electronic Publication: 2021 Nov 28.
DOI: 10.1080/02791072.2021.2006373
Abstrakt: Novel psychoactive substances have emerged as drugs of abuse. 2-Fluorodeschloroketamine (2-FDCK) is a ketamine derivative that can be purchased online for as little as $12 per gram. We report the case of a patient with a history of polysubstance use presenting after insufflation of 2-FDCK, with subsequent confirmation of metabolites in the patient's urine. A 28-year-old man presented to the Emergency Department in a dissociated state. He recovered well with supportive care, and described during interview his experience of substance use including the novel psychoactive substance 2-FDCK. A urine sample was sent for analysis and 2-FDCK metabolites were isolated. This case is concerning because 2-FDCK is a relatively new agent that has not yet been reported in the United States. It is easy to obtain over the internet and has significant abuse potential.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje